ArticleDalton transactions (Cambridge, England : 2003)2019
Dialing in on pharmacological features for a therapeutic antioxidant small molecule.
Article in Dalton transactions (Cambridge, England : 2003), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Metal-Free Ligand-Centered Radical Scavenging in Pyridine-Modified Tetraaza Macrocycles.European journal of organic chemistry · 2026Article
- Simplified synthesis of anti-oxidant small moleculeMethodsX · 2026Article
- Tailoring Antioxidant Activities: Metal-Type Dependent, Highly Active SOD or Catalase Mimetics.Inorganic chemistry · 2025Article
- Predicting pRSC advances · 2025Article
- Rings of Power: Controlling SOD Mimic Activity by the Addition of Pyridine Rings within the Pyridinophane Scaffold.Inorganic chemistry · 2024Article
- Pentadentate and Hexadentate Pyridinophane Ligands Support Reversible Cu(II)/Cu(I) Redox Couples.Inorganics · 2023Article
- Hydrogen Peroxide Disproportionation Activity Is Sensitive to Pyridine Substitutions on Manganese Catalysts Derived from 12-Membered Tetra-Aza Macrocyclic Ligands.Inorganic chemistry · 2023Article
- Increased Efficiency of a Functional SOD Mimic Achieved with Pyridine Modification on a Pyclen-Based Copper(II) Complex.Inorganic chemistry · 2023Article
- pH-dependent concatenation of an inorganic complex results in solid state helix formation.Inorganica chimica acta · 2022Article
- Assembly of Polyiodide Networks with Cu(II) Complexes of Pyridinol-Based Tetraaza Macrocycles.Inorganic chemistry · 2022Article
- A macrocyclic molecule with multiple antioxidative activities protects the lens from oxidative damage.Frontiers in chemistry · 2022Article
- Stabilisation of Exotic Tribromide (BrMolecules (Basel, Switzerland) · 2020Article
- Hydrogen Peroxide Disproportionation with Manganese Macrocyclic Complexes of Cyclen and Pyclen.Inorganic chemistry frontiers · 2020Article
- Synthesis of 12-Membered Tetra-aza Macrocyclic Pyridinophanes Bearing Electron-Withdrawing Groups.The Journal of organic chemistry · 2020Article
- Electronic influence of substitution on the pyridine ring within NNN pincer-type molecules.Dalton transactions (Cambridge, England : 2003) · 2020Article
- Functionalized pyridine in pyclen-based iron(iii) complexes: evaluation of fundamental properties.RSC advances · 2020Article
- Enhancement of the Antioxidant Activity and Neurotherapeutic Features through Pyridol Addition to Tetraazamacrocyclic Molecules.Inorganic chemistry · 2019Article
- Effect of 4-Position Pyridine Ring Substitution on Zn(II) Complexes of 4-substituted PyJournal of coordination chemistryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The pyridinophane molecule L2 (3,6,9,15-tetraazabicyclo[9.3.1]penta-deca-1(15),11,13-trien-13-ol) has shown promise as a therapuetic for neurodegenerative diseases involving oxidative stress and metal ion misregulation. Protonation and metal binding stability constants with Mg
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.